n Atrian Medical, a medtech start-up, has closed a €2.3 million seed round. The NUI Galway spin-out will use the funding to commercialise a new treatment for atrial fibrillation. The condition causes irregular heartbeats that result in palpitations, weakness, fatigue and dizziness.

The Atrian Medical device delivers electrical signals that knock out hyperactive nerve cells and reduce the overall sensitivity of the heart to atrial fibrillation. The technology was conceived at the Mayo Clinic in...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Willie O’Reilly: Trump gets personal with a special message

The debate on reopening society must be about more than health

Lucinda Creighton: Forget the exercise bike, the ‘perk’ your staff need is quality of life

Divisions emerge at Kerry Co-op over bid for Kerry Group’s dairy arm